Entourage Announces Results of 2023 Annual General Meeting of Shareholders
Entourage is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general meeting of shareholders (“AGM”) held virtually in Toronto, Ontario on June 14, 2023.
Entourage Health Reports First Quarter 2023 Financial Results
Entourage announced today its financial results for the three months ended March 31, 2023.
Entourage Health Reports Fiscal Year 2022 Financial Results and Posts $54.5 Million in Total Revenues
Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
Entourage announced today its financial results for the three and nine months ended September 30, 2022.
Entourage Health Reports Second Quarter 2022 Financial Results
Entourage announced today its financial results for the three and six months ended June 30, 2022.
Entourage Health Reports Record First Quarter 2022 Financial Results
Entourage Health Corp. announced today its financial results for the three months ended March 31, 2022.
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million
Entourage Health Corp. announced today its financial results for the fiscal year ended December 31, 2021.
Entourage Health Posts New Year 2022 Shareholder Newsletter
Entourage Health issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022.
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
Funding to enhance cultivation growth with tissue culture and market new genetics with premium products via Color Cannabis, Royal City Cannabis, Saturday Cannabis and Starseed Medicinal
Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in 2022
Company also confirms its certification as an Ontario Living Wage Employer, becoming one of only three cannabis cultivators with this distinction
Entourage Health Launches Cannabis-Infused Soft Chews for Starseed Medicinal Line
Company partners with Olli Brands Inc. to develop and curate a suite of premium CBD and THC soft chew products for release in its medical channel starting late November 2021
Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth
Entourage Health Corp. announced today its financial results for the three and nine months ended September 30, 2021.
Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth
Entourage Health Corp. announced today its financial results for the three and six months ended June 30, 2021.
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
Entourage Health Corp. is pleased to announce preliminary unaudited revenues of $13.6 million for the three months ended June 30, 2021, representing another sequential quarter of record sales growth across its adult-use and medical sales channels.
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth
WeedMD announced today its financial results for the three months ended March 31, 2021.
WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million
WeedMD announced today its financial results for the fiscal year ended December 31, 2020.